Home > Balance Sheet > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹4,102 Cr₹3,985 Cr₹2,588 Cr₹3,420 Cr₹2,254 Cr

What is the latest Capital Work in Progress ratio of BIOCON ?

The latest Capital Work in Progress ratio of BIOCON is ₹4,102 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹4,102 Cr
Mar2024₹3,985 Cr
Mar2023₹2,588 Cr
Mar2022₹3,420 Cr
Mar2021₹2,254 Cr

How is Capital Work in Progress of BIOCON Trending?

Years Capital Work in Progress % Change
Mar2025 ₹4,102 Cr
2.92
Mar2024 ₹3,985 Cr
54.02
Mar2023 ₹2,588 Cr
-24.35
Mar2022 ₹3,420 Cr
51.78
Mar2021 ₹2,254 Cr -

Compare Capital Work in Progress of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹51,133.6 Cr -4% 0.6% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,731.0 Cr -4.1% -2.1% -5.1% Stock Analytics
DIVIS LABORATORIES ₹172,373.0 Cr -2.8% -5.9% 29.2% Stock Analytics
CIPLA ₹122,411.0 Cr -3.7% 0.1% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,285.0 Cr -4.1% 7.3% 14.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,270.0 Cr -5.7% -6.1% -11.6% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-4%

0.6%

8%

SENSEX

0.2%

-2.7%

-0.9%


You may also like the below Video Courses